Aqua Bio Technology ASA (ABT) posted sales of NOK 0.7 million in the first half
of 2019, compared to NOK 0.6 million in the same period last year. Sales in the
first half were lower than expected at the beginning of the year, mainly due to
packaging problems for the Company's new skincare products.

ABT's EBITDA for the first half of 2019 was NOK -8.2 million, against NOK -8.6
million last year. Net result for the period came in at NOK -8.9 million,
compared to NOK -9.0 million in the first half of 2018.

The Company's sales and marketing efforts were intensified in the first half,
resulting in new distributor agreements. For the Moana Skincare series, ABT's
commercial rights were expanded beyond Europe, the Middle-East and Africa to
also include India, Indonesia and Hong Kong. Distributor agreements for these
territories, as well as for Russia, have been established. Following the
intensified marketing in the first half of the year, market interest in ABT's
skincare products is considered promising. Furthermore, the Company's is engaged
in discussions with several brand owners with the purpose of expanding its
portfolio of cosmetic products.

Aqua Bio Technology's new skincare ingredient, Spirulysat® will be launched in
the second half of the year. The ingredient will be marketed in several
territories. ABT's distribution partner for eight European markets is Active Box
of Italy, while discussions are ongoing with potential distributors in other
territories.

"With the difficulties of 2018 and the first half of 2019 behind us, encouraging
market interest in our skincare products, expansion into new territories and the
launch of our new ingredient, we forecast significant sales growth in the second
half of the year," said ABT's acting CEO Espen Kvale.

For further information, please call Edvard Cock, Chairman,  CEO, telephone
+47 4150 4004

Aqua   Bio  Technology  (ABT)  is  developing  and  commercializing  sustainable
biotechnology  for use  in skin  care products.  ABT's cosmetics ingredients are
highly   effective   and  they  provide  the  cosmetics  industry  with  natural
alternatives  to traditional ingredients. ABT is also marketing and distributing
natural   skin  care  products  developed  by  partners  towards  consumers  and
professional  users. Aqua Bio  Technology is listed  on the Axess  market of the
Oslo Stock Exchange.